(Q45928400)

English

Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group.

scientific article published on 15 July 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19605505

Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group. (English)

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19605505

0 references

1 reference

based on heuristic

inferred from title

3

object named as

M Kundi

1 reference

Europe PubMed Central

17 December 2017

author name string

W R Sperr

1

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19605505

F Wimazal

2

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19605505

C Baumgartner

4

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19605505

T Nösslinger

5

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19605505

A Makrai

6

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19605505

R Stauder

7

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19605505

O Krieger

8

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19605505

M Pfeilstöcker

9

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19605505

P Valent

10

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19605505

publication date

15 July 2009

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19605505

Annals of Oncology

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19605505

21

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19605505

1

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19605505

114-119

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19605505

Treatment and prognostic factors in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP258

21 January 2018

Epidemiologic perspectives on myelodysplastic syndromes and leukemia

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP258

21 January 2018

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP258

21 January 2018

Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP258

21 January 2018

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP258

21 January 2018

The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP258

21 January 2018

A comparative review of classification systems in myelodysplastic syndromes (MDS).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP258

21 January 2018

Risk factors and their relationship to prognosis in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP258

21 January 2018

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP258

21 January 2018

Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP258

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP258

21 January 2018

Myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP258

21 January 2018

The myelodysplastic syndromes: diagnosis, molecular biology and risk assessment

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP258

21 January 2018

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP258

21 January 2018

Individualized management and therapy of myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP258

21 January 2018

Impact of acquired comorbidities on all-cause mortality rates among older breast cancer survivors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP258

21 January 2018

Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP258

21 January 2018

Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP258

21 January 2018

Non-Hodgkin's lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP258

21 January 2018

Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP258

21 January 2018

Identifiers

10.1093/ANNONC/MDP258

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19605505

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19605505

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45928400&oldid=1530845649"